(1S,5S)-6-BENZYL-2-METHOXY-8-METHYL-2-(TRIMETHYLSILOXY)-6,8-DIAZABICYCLO-[3.2.2]-NONANE-7,9-DIONE
Compound with spectra: 1 NMR
![(1S,5S)-6-BENZYL-2-METHOXY-8-METHYL-2-(TRIMETHYLSILOXY)-6,8-DIAZABICYCLO-[3.2.2]-NONANE-7,9-DIONE](/api/compound/4Ls2BOKyNC7.png?ph=true&h=300&w=458 "(1S,5S)-6-BENZYL-2-METHOXY-8-METHYL-2-(TRIMETHYLSILOXY)-6,8-DIAZABICYCLO-[3.2.2]-NONANE-7,9-DIONE")
| SpectraBase Compound ID | 4Ls2BOKyNC7 |
|---|---|
| InChI | InChI=1S/C19H28N2O4Si/c1-20-16-18(23)21(13-14-9-7-6-8-10-14)15(17(20)22)11-12-19(16,24-2)25-26(3,4)5/h6-10,15-16H,11-13H2,1-5H3/t15-,16+,19-/m0/s1 |
| InChIKey | MSSQISDUKPXUDW-FCEWJHQRSA-N |
| Mol Weight | 376.53 g/mol |
| Molecular Formula | C19H28N2O4Si |
| Exact Mass | 376.181834 g/mol |
| Enantiomer InChIKey | MSSQISDUKPXUDW-JTDSTZFVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-Oxa-6,8-diazabicyclo[3.2.2]non-3-ene-7,9-dione, 4-ethenyl-6,8-bis[(4-methoxyphenyl)methyl]-3-methyl-
Ethyl (1S,2R,4R,5R)-4-[(2S)-2-acetoxy-2-phenylacetoxy]-2-hydroxy-5-methyl-2-(2-trimethylsilyl-3-furyl)cyclohexanecarboxylate
Carbamic acid, [4-[3-benzoyl-2-(1,1-dimethylethyl)-4-(1-hydroxyethyl)-1-methyl-5-oxo-4-imidazolidinyl]butyl]-, phenylmethyl ester, [2S-[2.alpha.,4.beta.(S*)]]-
AMPHIBINE-E
Methyl 8b-(phenylsulfanyl)-6-methyl-1,2,2a,3,4,8b-hexahydro-cyclobuta[a]naphthalene-3-carboxylate
DIHYDROVITTALINE
Crinan-3-ol, (3.alpha.)-
9,9a-dihydro-7-methoxy-6,9.beta.-dimethyl-3H-pyrrolo[1,2-a]indole-5,8-dione
Methanone, [2,5-dihydro-4-(4-methoxyphenyl)-2,2,5-triphenyl-5-oxazolyl]phenyl-
2-(7-methyl-6H-indolo[2,3-b]quinoxalin-6-yl)ethyl benzoate
| Title | Journal or Book | Year |
|---|---|---|
| Conformationally constrained ethylenediamines: synthesis and receptor binding of 6,8-Diazabicyclo[3.2.2]nonanes | Bioorganic & Medicinal Chemistry | 2002 |